University of Alberta scientists find a new application for an existing drug, with potential to slow progression of the devastating degenerative disease.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig’s disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
The drug, called telbivudine, targets a protein that misfolds and does not function correctly in patients with ALS. “SOD1 is a protein that is known to misfold and misbehave in most cases of patients with ALS,” explained Ted Allison, associate professor in the Department of Biological Sciences and co-author on the study. “We showed that telbivudine can greatly reduce the toxic properties of SOD1, including improving the health of the subject’s motor neurons and improving movement.”
The research team used computer simulations to identify drugs with the potential for targeting the SOD1 protein. From this shortlist, the scientists identified and tested the most likely candidates—including telbivudine—using animal models.
“ALS is not well-understood,” said lead author Michele DuVal, who recently completed the PhD portion of the Faculty of Medicine & Dentistry’sMD/PhD program under the supervision of Allison. “We don’t yet know exactly what goes wrong first in the motor neurons or how the misbehaving SOD1 causes toxicity. Because there is still much to learn about the disease, the ALS research community focuses on both understanding ALS and on developing promising therapies.”
The discovery of telbivudine as a potential treatment is particularly exciting because the drug is already in use for treating patients with hepatitis. “It is already proven safe to use in patients, and it has very good potential for repurposing to use in a new clinical setting against ALS,” said Allison.
Learn more: Biologists identify promising drug for ALS treatment
The Latest on: Lou Gehrig’s disease
[google_news title=”” keyword=”Lou Gehrig’s disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Lou Gehrig’s disease
- Canadian researchers unlock potential ‘cure’ for ALSon May 14, 2024 at 7:41 am
By Ashley Hyshka Click here for updates on this story LONDON, ONTARIO (CTV Network) — New research out of London, Ont.’s Western University is shedding light on a potential cure for ALS, in which the ...
- Breakthrough research reveals potential path toward a cure for ALSon May 14, 2024 at 12:47 am
In a groundbreaking Canadian discovery powered by philanthropy, a team of Western University researchers led by Dr. Michael Strong has uncovered a potential path toward a cure for amyotrophic lateral ...
- Western University researchers make breakthrough on possible ALS treatmenton May 13, 2024 at 1:57 pm
Researchers at Western University have made a discovery, showing that a protein can reverse, halt or prevent the death of motor neurons.
- A promising new study could lead to a reduction in symptoms of amyotrophic lateral sclerosis (ALS)on May 13, 2024 at 9:15 am
A new study shows that it is possible to reduce the symptoms of amyotrophic lateral sclerosis by reducing the inflammation caused by immune cells in the brain.
- At 22, he got a million-to-1 fatal disease. So why is he still smiling?on May 13, 2024 at 3:00 am
A 22-year-old man from Mount Pleasant diagnosed with amyotrophic lateral sclerosis says he won't give in to his fatal disease and hopes to see a cure one day.
- Health Spotlight: The accidental discovery to treat IBDon May 10, 2024 at 12:14 pm
It has been found that inhibition of a specific brain enzyme can be therapeutic in animal models of stroke, epilepsy, and more.
- 'You become a prisoner of your own body': Local woman advocates for research after father loses battle to ALSon May 10, 2024 at 9:31 am
ALS or Amyotrophic Lateral Sclerosis, better known to many as Lou Gehrig's Disease, is a degenerative nervous system disease that weakens muscles and impacts total body function.
- Watch Trailer For ‘For Love & Life: No Ordinary Campaign,’ Inspiring Story About Founders Of I Am ALSon May 6, 2024 at 8:00 am
At the age of 43 and a half now, he has already long outlived the predictions he heard when he was first diagnosed with ALS, also known as Lou Gehrig’s Disease, in 2017. His doctor at that time only ...
- Growing HS baseball/softball tournament working to Strike Out Lou Gehrig's Diseaseon May 3, 2024 at 11:29 am
High school baseball and softball teams from sections III and V meet for games in annual ALS Association fundraiser.
- Deseret News archives: Lessons from Lou Gehrig’s lifeon May 2, 2024 at 1:56 pm
There were no page-topping headlines in newspapers around the world announcing that on May 2, 1939, Lou Gehrig of the New York Yankees did not play against the Detroit Tigers at Briggs Stadium, ending ...
via Bing News